NEW YORK, Oct. 17, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning,
Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of SunOpta, Inc.
(NASDAQ:STKL), Acorda Therapeutics, Inc. (NASDAQ:ACOR), Sapiens International Corporation N.V. (NASDAQ:SPNS), The Descartes Systems
Group Inc. (NASDAQ:DSGX), Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN), and CSS Industries, Inc. (NYSE:CSS), including updated
fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
STKL DOWNLOAD: http://Fundamental-Markets.com/register/?so=STKL
ACOR DOWNLOAD: http://Fundamental-Markets.com/register/?so=ACOR
SPNS DOWNLOAD: http://Fundamental-Markets.com/register/?so=SPNS
DSGX DOWNLOAD: http://Fundamental-Markets.com/register/?so=DSGX
ACHN DOWNLOAD: http://Fundamental-Markets.com/register/?so=ACHN
CSS DOWNLOAD: http://Fundamental-Markets.com/register/?so=CSS
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Fundamental Markets, available for free download at the links above, examine
SunOpta, Inc. (NASDAQ:STKL), Acorda Therapeutics, Inc. (NASDAQ:ACOR), Sapiens International Corporation N.V. (NASDAQ:SPNS), The
Descartes Systems Group Inc. (NASDAQ:DSGX), Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN), and CSS Industries, Inc. (NYSE:CSS) on a
fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business
strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are
available to today's readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone
summaries and as such, important information may be missing from these samples. Please download the entire research report, free of
charge, to ensure you are reading all relevant material information. All information in this release was accessed October 15th,
2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
SUNOPTA, INC. (STKL) REPORT OVERVIEW
SunOpta's Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, SunOpta reported revenue of $319.31MM vs
$336.45MM (down 5.10%) and analysts estimated basic earnings per share -$0.06 vs -$0.03. For the twelve months ended December 31st,
2017 vs December 31st, 2016, SunOpta reported revenue of $1,279.59MM vs $1,346.73MM (down 4.99%) and analysts estimated basic
earnings per share -$1.66 vs -$0.62. Analysts expect earnings to be released on November 14th, 2018. The report will be for the
fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was -$0.02. The estimated EPS forecast
for the next fiscal year is $0.03 and is expected to report on February 26th, 2019.
To read the full SunOpta, Inc. (STKL) report, download it here: http://Fundamental-Markets.com/register/?so=STKL
-----------------------------------------
ACORDA THERAPEUTICS, INC. (ACOR) REPORT OVERVIEW
Acorda Therapeutics' Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, Acorda Therapeutics reported revenue of $153.30MM
vs $139.44MM (up 9.94%) and analysts estimated basic earnings per share $0.99 vs -$0.18. For the twelve months ended December 31st,
2017 vs December 31st, 2016, Acorda Therapeutics reported revenue of $588.29MM vs $519.60MM (up 13.22%) and analysts estimated
basic earnings per share -$4.86 vs -$0.76. Analysts expect earnings to be released on October 30th, 2018. The report will be for
the fiscal period ending September 30th, 2018. Reported EPS for the same quarter last year was -$0.55. The estimated EPS forecast
for the next fiscal year is -$3.79 and is expected to report on February 21st, 2019.
To read the full Acorda Therapeutics, Inc. (ACOR) report, download it here: http://Fundamental-Markets.com/register/?so=ACOR
-----------------------------------------
SAPIENS INTERNATIONAL CORPORATION N.V. (SPNS) REPORT OVERVIEW
Sapiens International Corporation N.V's Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, Sapiens International Corporation N.V reported
revenue of $72.16MM vs $69.05MM (up 4.51%) and analysts estimated basic earnings per share $0.04 vs -$0.07. For the twelve months
ended December 31st, 2017 vs December 31st, 2016, Sapiens International Corporation N.V reported revenue of $269.19MM vs $216.19MM
(up 24.52%) and analysts estimated basic earnings per share $0.01 vs $0.40 (down 97.50%). Analysts expect earnings to be released
on November 8th, 2018. The report will be for the fiscal period ending September 30th, 2018. Reported EPS for the same quarter last
year was $0.12. The estimated EPS forecast for the next fiscal year is $0.54 and is expected to report on March 14th, 2019.
To read the full Sapiens International Corporation N.V. (SPNS) report, download it here: http://Fundamental-Markets.com/register/?so=SPNS
-----------------------------------------
THE DESCARTES SYSTEMS GROUP INC. (DSGX) REPORT OVERVIEW
The Descartes Systems Group's Recent Financial Performance
For the three months ended July 31st, 2018 vs July 31st, 2017, The Descartes Systems Group reported revenue of
$67.12MM vs $57.29MM (up 17.14%) and basic earnings per share $0.11 vs $0.09 (up 22.22%). For the twelve months ended January 31st,
2018 vs January 31st, 2017, The Descartes Systems Group reported revenue of $237.44MM vs $203.78MM (up 16.52%) and analysts
estimated basic earnings per share $0.35 vs $0.31 (up 12.90%). Analysts expect earnings to be released on December 5th, 2018. The
report will be for the fiscal period ending October 31st, 2018. The reported EPS for the same quarter last year was $0.08. The
estimated EPS forecast for the next fiscal year is $0.54 and is expected to report on March 4th, 2019.
To read the full The Descartes Systems Group Inc. (DSGX) report, download it here: http://Fundamental-Markets.com/register/?so=DSGX
-----------------------------------------
ACHILLION PHARMACEUTICALS, INC. (ACHN) REPORT OVERVIEW
Achillion Pharmaceuticals' Recent Financial Performance
Analysts expect earnings to be released on November 7th, 2018. The report will be for the fiscal period ending
September 30th, 2018. The reported EPS for the same quarter last year was -$0.14. The estimated EPS forecast for the next fiscal
year is -$0.61 and is expected to report on February 28th, 2019.
To read the full Achillion Pharmaceuticals, Inc. (ACHN) report, download it here: http://Fundamental-Markets.com/register/?so=ACHN
-----------------------------------------
CSS INDUSTRIES, INC. (CSS) REPORT OVERVIEW
CSS Industries' Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, CSS Industries reported revenue of $64.13MM vs
$48.32MM (up 32.70%) and analysts estimated basic earnings per share -$2.03 vs -$0.78. For the twelve months ended March 31st, 2018
vs March 31st, 2017, CSS Industries reported revenue of $361.90MM vs $322.43MM (up 12.24%) and analysts estimated basic earnings
per share -$4.01 vs $3.14. Analysts expect earnings to be released on November 6th, 2018. The report will be for the fiscal period
ending September 30th, 2018. The reported EPS for the same quarter last year was $0.65. The estimated EPS forecast for the next
fiscal year is $1.00 and is expected to report on May 30th, 2019.
To read the full CSS Industries, Inc. (CSS) report, download it here: http://Fundamental-Markets.com/register/?so=CSS
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members and have provided research through some of the world's leading
brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals
worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA®
BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst®
(CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers
("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes
qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers.
Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit
firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries
regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail
at compliance@Fundamental-Markets.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental
Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result
from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the
material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the
publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm,
investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full
disclaimer, disclosure, and terms of service please visit our website.
Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com
© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network
manager at partnership@Fundamental-Markets.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority,
Inc.
